Grenil 5mg/250mg Suspension is a combination pharmaceutical formulation containing Domperidone 5mg and Paracetamol 250mg per dose, designed for oral administration. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastrointestinal motility and acts as an antiemetic by enhancing gastric emptying and reducing nausea and vomiting. Paracetamol, a widely used analgesic and antipyretic agent, provides effective relief from mild to moderate pain and reduces fever through central inhibition of prostaglandin synthesis. Grenil Suspension is indicated for the symptomatic treatment of conditions associated with nausea, vomiting, and pain, including gastrointestinal disorders and febrile states. The suspension form allows for ease of administration, particularly in pediatric and geriatric populations who may have difficulty swallowing tablets. Dosage should be individualized based on patient age, weight, and clinical condition, adhering to recommended guidelines to minimize the risk of adverse effects. Common side effects may include dry mouth, abdominal cramps, or allergic reactions. Caution is advised in patients with hepatic or renal impairment, and concurrent use with other medications should be monitored to avoid potential drug interactions. Grenil 5mg/250mg Suspension should be used under medical supervision to ensure safety and therapeutic efficacy.